Spandow Oliver J. 4
4 · NEPHROS INC · Filed Jan 9, 2023
Insider Transaction Report
Form 4
NEPHROS INCNEPH
Spandow Oliver J.
Director
Transactions
- Award
Common Stock
2023-01-05+42,481→ 67,310 total - Award
Stock Option (Right to Buy)
2023-01-05+7,080→ 7,080 totalExercise: $1.07Exp: 2032-01-05→ Common Stock (7,080 underlying)
Holdings
- 9,466
Stock Option (Right to Buy)
Exercise: $5.58Exp: 2028-08-10→ Common Stock (9,466 underlying) - 5,161
Stock Option (Right to Buy)
Exercise: $5.85Exp: 2028-12-19→ Common Stock (5,161 underlying) - 5,568
Stock Option (Right to Buy)
Exercise: $8.57Exp: 2029-12-16→ Common Stock (5,568 underlying) - 7,062
Stock Option (Right to Buy)
Exercise: $6.82Exp: 2031-12-14→ Common Stock (7,062 underlying) - 6,850
Stock Option (Right to Buy)
Exercise: $8.06Exp: 2031-01-06→ Common Stock (6,850 underlying)
Footnotes (4)
- [F1]Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors for 2022. These shares of restricted stock vest 6 months following the grant date.
- [F2]Fully exercisable.
- [F3]This option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23.
- [F4]Represents options granted to the reporting person for his service on the Company's Board of Directors for 2022. This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25.